![Andrew Reardon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Reardon
Direktor/Vorstandsmitglied bei
VERNALIS
Vermögen: 10 Mio $ am 31.05.2026
Profil
Andrew Thomas Reardon is currently Director at Ligand UK Ltd. since 2022 and Secretary & Chief Legal Officer at Ligand Pharmaceuticals, Inc. since 2022.
Former positions include Senior Associate at Willkie Farr & Gallagher LLP, Principal at The United States Army (District of Columbia), and Vice President-Legal at Healthcare Royalty Management LLC.
Education includes graduate studies at The University of Iowa College of Law and undergraduate studies at State University of New York at Old Westbury.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.06.2026 | 41’382 ( 0.21% ) | 10 Mio $ | 31.05.2026 |
Aktive Positionen von Andrew Reardon
| Unternehmen | Position | Beginn |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | General Counsel | 01.01.2022 |
| VERNALIS | Direktor/Vorstandsmitglied | 01.11.2022 |
Ehemalige bekannte Positionen von Andrew Reardon
| Unternehmen | Position | Ende |
|---|---|---|
Willkie Farr & Gallagher LLP
 Willkie Farr & Gallagher LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
The United States Army (District of Columbia)
 The United States Army (District of Columbia) SovereignGovernment Engages in army operations | Corporate Officer/Principal | - |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the field of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt. | Corporate Officer/Principal | - |
Ausbildung von Andrew Reardon
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
12
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Ligand UK Ltd.
 Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
Willkie Farr & Gallagher LLP
Willkie Farr & Gallagher LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
State University of New York at Old Westbury
 State University of New York at Old Westbury Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The United States Army (District of Columbia)
The United States Army (District of Columbia) SovereignGovernment Engages in army operations | Government |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the field of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt. | Finance |
The University of Iowa College of Law
 The University of Iowa College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
